SAN FRANCISCO, Calif.,
July 24, 2017 /PRNewswire/
-- Kindred Biosciences, Inc. (NASDAQ: KIN), a
biopharmaceutical company focused on saving and improving the lives
of pets, today announced that it will release its second quarter
2017 financial results on August 7,
2017 after the market close. The Company will host a
conference call at 4:30 p.m. Eastern
Time / 1:30 p.m. Pacific Time
that day.
Interested parties may access the call by dialing toll-free
(855) 433-0927 from the US, or (484) 756-4262 internationally, and
using conference ID 56145078.
The call will also be webcast live at
http://edge.media-server.com/m/p/manjktch.
A replay will also be available at that link for 30 days.
About Kindred Biosciences
Kindred Biosciences is a development-stage biopharmaceutical
company focused on saving and improving the lives of pets.
Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The
Company's strategy is to identify compounds and targets that have
already demonstrated safety and efficacy in humans and to develop
therapeutics based on these validated compounds and targets for
dogs, cats and horses. The Company has a deep pipeline of
novel drugs and biologics in development across many therapeutic
classes.
For more information or to download the corporate presentation,
visit www.KindredBio.com/LearnMore. Stay connected with KindredBio
on Facebook at www.Facebook.com/KindredBio.
Contact
Russell
Radefeld
KindredBio
russell.radefeld@kindredbio.com
(650) 701-7904
View original content with
multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-second-quarter-2017-financial-results-300492625.html
SOURCE Kindred Biosciences, Inc.